We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Less Expensive, More Effective, and Safer Diagnosis of Breast Cancer in Development

By HospiMedica International staff writers
Posted on 20 Mar 2011
New computational technology has led to a fast, inexpensive technique for using ultrasound, and advanced algorithms to differentiate between benign and malignant tumors with a high level of accuracy. More...


Sevan Goenezen is a doctoral student in the department of mechanical, aerospace, and nuclear engineering at Rensselaer Polytechnic Institute (Troy, NY, USA) and his research offers the potential of greatly reducing the need for invasive, uncomfortable, and stress-inducing biopsies, and possibly even replacing mammograms. It uses a new technique to assess images captured with a noninvasive, radiation-free ultrasound device, locate tumors, and determine if the tumor is malignant. The only required equipment is a specific type of ultrasound machine--which typically costs about US$10,000, far less than X-ray equipment--and a common personal computer (PC). Due to these new algorithms, results can be computed in less than five minutes on a high-end PC.

This new technique utilizes ultrasound images of breast tissue to infer the mechanical characteristics of the tissue as it is compressed. The structure of collagen fibers within malignant tissues is very different from the collagen fiber structure in benign tissue. This method quantifies the non-linear behavior of the tumor tissue to determine whether it is cancerous.

In a clinical study, Dr. Goenezen used this strategy to analyze 10 data sets, 5 of which were from patients with benign tumors, and 5 with malignant tumors. The system correctly diagnosed 9 out of the 10 patients. The lone error was a false positive
.
Dr. Goenezen is confident that this new method could lead to less expensive, more effective, and safer diagnosis of breast cancer, which holds the potential to save many lives and significantly trim the screening costs for patients, physicians, and hospitals. Moreover, he reported that he believes this new method could be adapted to diagnose other diseases, including prostate cancer, cervical cancer, liver cirrhosis, and atherosclerosis.

Related Links:
Rensselaer Polytechnic Institute


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
OR Table Accessory
Angular Accessory Rail
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.